The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Natuk, R. J.
Right arrow Articles by Welsh, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Natuk, R. J.
Right arrow Articles by Welsh, R. M.

The Journal of Immunology, Vol 138, Issue 3 877-883, Copyright © 1987 by American Association of Immunologists


ARTICLES

Accumulation and chemotaxis of natural killer/large granular lymphocytes at sites of virus replication

RJ Natuk and RM Welsh

A model for monitoring the accumulation of natural killer cell/large granular lymphocytes (NK/LGL) at a site of virus replication was studied by using mice infected i.p. with either lymphocytic choriomeningitis virus (LCMV), murine cytomegalovirus (MCMV), mouse hepatitis virus (MHV), Pichinde virus, or vaccinia virus. An i.p. but not i.v. infection resulted in a localized increase in NK/LGL cell number (a fourfold to greater than 20-fold increase) and augmentation (a 10- to 20-fold increase) of NK cell activity associated with virus- induced peritoneal exudate cell (PEC) populations. An increase in NK/LGL cell number was detected as early as 12 hr postinfection (p.i.) and peaked at 3 days p.i. with MHV. The initial LGL recruited into the peritoneal cavity at 1 to 3 days p.i. were nonadherent to plastic and were demonstrated to have an NK cell phenotype: asialo GM1+, Thy-1.2 +/- , Lyt-2.2-, and J11d-. The peak number of LGL appeared at 7 days after infection with the NK cell-resistant virus, LCMV. This LGL population had been previously demonstrated to contain cytotoxic T lymphocyte/LGL (CTL/LGL) as well as NK/LGL. During an MHV infection the number of LGL decreased between days 3 and 7 p.i., suggesting that the second wave of CTL/LGL was absent. These findings may explain the absence of a good MHV-CTL model. Virus-induced, activated NK/LGL responded to chemotactic signals by migrating in a unidirectional manner across two 5-microns pore size polycarbonate filters during 7 hr in vitro chemotaxis assays. Wash-out fluid obtained from the peritoneal cavity contained chemotactic activity for NK/LGL as well as for other cell types. We conclude that production and/or release of chemotactic factors at sites of virus replication are at least partially responsible for the accumulation of NK/LGL at these sites.


This article has been cited by other articles:


Home page
J. Gen. Virol.Home page
N. Jacobs, R. A.-J. Chen, C. Gubser, P. Najarro, and G. L. Smith
Intradermal immune response after infection with Vaccinia virus.
J. Gen. Virol., May 1, 2006; 87(Pt 5): 1157 - 1161.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. E. Chisholm and H. T. Reyburn
Recognition of Vaccinia Virus-Infected Cells by Human Natural Killer Cells Depends on Natural Cytotoxicity Receptors
J. Virol., March 1, 2006; 80(5): 2225 - 2233.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
J. J. Endsley, M. A. Endsley, and D. M. Estes
Bovine natural killer cells acquire cytotoxic/effector activity following activation with IL-12/15 and reduce Mycobacterium bovis BCG in infected macrophages
J. Leukoc. Biol., January 1, 2006; 79(1): 71 - 79.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Prlic, J. Gibbs, and S. C. Jameson
Characteristics of NK Cell Migration Early after Vaccinia Infection
J. Immunol., August 15, 2005; 175(4): 2152 - 2157.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
D. Markine-Goriaynoff, X. Hulhoven, C. L. Cambiaso, P. Monteyne, T. Briet, M.-D. Gonzalez, P. Coulie, and J.-P. Coutelier
Natural killer cell activation after infection with lactate dehydrogenase-elevating virus
J. Gen. Virol., November 1, 2002; 83(11): 2709 - 2716.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
K. A. Daniels, G. Devora, W. C. Lai, C. L. O'Donnell, M. Bennett, and R. M. Welsh
Murine Cytomegalovirus Is Regulated by a Discrete Subset of Natural Killer Cells Reactive with Monoclonal Antibody to Ly49H
J. Exp. Med., June 25, 2001; 194(1): 29 - 44.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
R. Glas, L. Franksson, C. Une, M.-L. Eloranta, C. Ohlen, A. Orn, and K. Karre
Recruitment and Activation of Natural Killer (NK) Cells In Vivo Determined by the Target Cell Phenotype: An Adaptive Component of NK Cell-mediated Responses
J. Exp. Med., January 3, 2000; 191(1): 129 - 138.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Frey, N. B. Packianathan, T. A. Fehniger, M. E. Ross, W.-C. Wang, C. C. Stewart, M. A. Caligiuri, and S. S. Evans
Differential Expression and Function of L-Selectin on CD56bright and CD56dim Natural Killer Cell Subsets
J. Immunol., July 1, 1998; 161(1): 400 - 408.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
L. Pazmany, O. Mandelboim, M. Valés-Gómez, D. M. Davis, H. T. Reyburn, and J. L. Strominger
Protection from Natural Killer Cell-Mediated Lysis by HLA-G Expression on Target Cells
Science, November 1, 1996; 274(5288): 792 - 795.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. Andre, O. Spertini, S. Guia, P. Rihet, F. Dignat-George, H. Brailly, J. Sampol, P. J. Anderson, and E. Vivier
Modification of P-selectin glycoprotein ligand-1 with a natural killer cell-restricted sulfated lactosamine creates an alternate ligand for L-selectin
PNAS, March 28, 2000; 97(7): 3400 - 3405.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1987 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1987 by The American Association of Immunologists, Inc. All rights reserved.